Thomas VanCott

Director Ejecutivo en

Excellos, Inc.

Consumer Services

Health Technology

Perfil

Thomas C.
VanCott is Chief Executive Officer & Director at Excellos, Inc. since 2024.
Formerly, Dr. VanCott was President & Chief Executive Officer at Advanced BioScience Laboratories, Inc. from 2004 to 2018.
Education includes a doctorate from the University of Virginia and an undergraduate degree from Dickinson College.

Cargos activos de Thomas VanCott

Empresas	Cargo	Inicio
Excellos, Inc. Excellos, Inc. BiotechnologyHealth Technology Operates as a cell therapy contract development and manufacturing organization	Director Ejecutivo	07/05/2024

Todos los cargos activos de Thomas VanCott

Antiguos cargos conocidos de Thomas VanCott.

Empresas	Cargo	Fin
Advanced BioScience Laboratories, Inc. Advanced BioScience Laboratories, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization dedicated to advancing therapeutics, vaccines & biological products	Director Ejecutivo	12/11/2018

Ver el detalle de la experiencia de Thomas VanCott.

Formación de Thomas VanCott.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Thomas VanCott.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
University of Virginia University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Dickinson College Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Advanced BioScience Laboratories, Inc. Advanced BioScience Laboratories, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization dedicated to advancing therapeutics, vaccines & biological products	Health Technology
Excellos, Inc. Excellos, Inc. BiotechnologyHealth Technology Operates as a cell therapy contract development and manufacturing organization	Health Technology